Tests Of Russian Vaccine Against Coronavirus Have Reached The Final Stage - Ministry Of Health

Table of contents:

Tests Of Russian Vaccine Against Coronavirus Have Reached The Final Stage - Ministry Of Health
Tests Of Russian Vaccine Against Coronavirus Have Reached The Final Stage - Ministry Of Health

Video: Tests Of Russian Vaccine Against Coronavirus Have Reached The Final Stage - Ministry Of Health

Отличия серверных жестких дисков от десктопных
Video: Russia's Sputnik V vaccine: What the experts say | COVID-19 Special 2023, January
Anonim

Tests of Russian vaccine against coronavirus have reached the final stage - Ministry of Health

The second phase of clinical trials of the drug, created by specialists of the Research Center for Microbiology and Epidemiology named after V.I. N.F. Gamaleya, is nearing completion, after which the issue of state registration of the vaccine will be decided.

Tests of Russian vaccine against coronavirus have reached the final stage - Ministry of Health
Tests of Russian vaccine against coronavirus have reached the final stage - Ministry of Health

Photo: vesti.ru

“Currently, the II phase of clinical trials of the vaccine developed by the Research Center for Microbiology and Epidemiology named after N.F. Gamaleya of the Ministry of Health of Russia continues and is at the final stage. Upon their completion, the issue of its state registration will be resolved,”RIA Novosti quotes the Ministry of Health.

Clinical trials of the Russian drug began on June 18 at the Burdenko military hospital and the Sechenov University with the participation of two groups of volunteers of 38 people each. A vaccine developed by scientists at the Center for Epidemiology and Microbiology. N.F. Gamalea, has two forms - in the form of liquid and powder for solution preparation. Both forms are intended for intramuscular administration.

Analyzes of volunteers from both groups showed that they had developed an immune response to coronavirus infection - this is a key indicator of the effectiveness of the vaccine. On July 13, study participants in the second group received a second dose of vaccine. The first injection was to test the effectiveness and immunogenicity of the drug, the second was to strengthen the immune system and increase its duration. On July 15, volunteers from the first group, with the help of which the tolerance and safety of the drug were tested, were discharged from the hospital.

As reported earlier in the Ministry of Defense, all test participants feel good, their psychological and moral state is also normal. No side effects of the vaccine have been identified. On the 42nd day after vaccination, the volunteers will have to return to the hospital for a final medical examination and registration of the necessary documentation.

Popular by topic